Evidence map›Paper›PMID 41908603›Full record

ArticleInfection and drug resistance2026

Combination of Ceftazidime-Avibactam and Aztreonam Effectively Treated Post-Cardiac Surgery Pneumonia Caused by Hypervirulent KPC- and NDM-Producing

Qimei Wei, Rong Cong, Chang Shen, Chen Chen, Zheng Cao, Chanjun Ren, Tingting Liu

Abstract readCase Reports
In one paragraph

Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qimei Wei *Department of Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan, 430022, People's Republic of China.
Rong Cong *Department of Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan, 430022, People's Republic of China.
Chang ShenDepartment of Cardiac Critical Care Medicine, Wuhan Asia Heart Hospital, Wuhan, 430022, People's Republic of China.
Chen ChenDepartment of Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan, 430022, People's Republic of China.
Zheng CaoDepartment of Clinical Laboratory, Wuhan Asia Heart Hospital, Wuhan, 430022, People's Republic of China.
Chanjun RenDepartment of Laboratory Medicine, Wuhan Kingmed Center for Clinical Laboratory, Wuhan, 430022, People's Republic of China.
Tingting LiuDepartment of Cardiac Critical Care Medicine, Wuhan Asia Heart Hospital, Wuhan, 430022, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hypervirulent carbapenem‑resistant Case Presentation: A 59‑year‑old woman developed severe pneumonia and acute respiratory distress syndrome following cardiac surgery. Bronchoalveolar lavage fluid culture yielded carbapenem‑resistant Conclusion: This case demonstrates that CZA combined with ATM may be an effective therapeutic option for severe infections caused by hypervirulent KPC‑2‑ and NDM‑1‑producing

Indexed as

aztreonamCarbapenem-resistant  Klebsiella pneumoniaeceftazidime-avibactamhypervirulent  Klebsiella pneumoniaeKPCNDM

Identifiers

PMID41908603
PMCPMC13025714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.